Azarian Taj, Grant Lindsay R, Georgieva Maria, Hammitt Laura L, Reid Raymond, Bentley Stephen D, Goldblatt David, Santosham Mathuran, Weatherholtz Robert, Burbidge Paula, Goklish Novalene, Thompson Claudette M, Hanage William P, O'Brien Kate L, Lipsitch Marc
Center for Communicable Disease Dynamics, Department of Epidemiology, T. H. Chan School of Public Health, Harvard University, Boston, Massachusetts, USA.
Center for American Indian Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.
J Infect Dis. 2017 Mar 1;215(5):713-722. doi: 10.1093/infdis/jiw628.
Several Streptococcus pneumoniae proteins play a role in pathogenesis and are being investigated as vaccine targets. It is largely unknown whether naturally acquired antibodies reduce the risk of colonization with strains expressing a particular antigenic variant.
Serum immunoglobulin G (IgG) titers to 28 pneumococcal protein antigens were measured among 242 individuals aged <6 months-78 years in Native American communities between 2007 and 2009. Nasopharyngeal swabs were collected >- 30 days after serum collection, and the antigen variant in each pneumococcal isolate was determined using genomic data. We assessed the association between preexisting variant-specific antibody titers and subsequent carriage of pneumococcus expressing a particular antigen variant.
Antibody titers often increased across pediatric groups before decreasing among adults. Individuals with low titers against group 3 pneumococcal surface protein C (PspC) variants were more likely to be colonized with pneumococci expressing those variants. For other antigens, variant-specific IgG titers do not predict colonization.
We observed an inverse association between variant-specific antibody concentration and homologous pneumococcal colonization for only 1 protein. Further assessment of antibody repertoires may elucidate the nature of antipneumococcal antibody-mediated mucosal immunity while informing vaccine development.
几种肺炎链球菌蛋白在发病机制中起作用,正作为疫苗靶点进行研究。目前尚不清楚自然获得的抗体是否能降低感染表达特定抗原变体菌株的定植风险。
2007年至2009年间,在美洲原住民社区对242名年龄在6个月至78岁之间的个体测量了针对28种肺炎球菌蛋白抗原的血清免疫球蛋白G(IgG)滴度。在血清采集后30天以上采集鼻咽拭子,并使用基因组数据确定每个肺炎球菌分离株中的抗原变体。我们评估了预先存在的变体特异性抗体滴度与随后携带表达特定抗原变体的肺炎球菌之间的关联。
抗体滴度通常在儿童组中升高,然后在成人中下降。针对3型肺炎球菌表面蛋白C(PspC)变体滴度较低的个体更有可能被表达这些变体的肺炎球菌定植。对于其他抗原,变体特异性IgG滴度不能预测定植情况。
我们仅观察到1种蛋白的变体特异性抗体浓度与同源肺炎球菌定植之间存在负相关。进一步评估抗体库可能有助于阐明抗肺炎球菌抗体介导的粘膜免疫的性质,同时为疫苗开发提供信息。